# Dan Ding

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dan-ding/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,471 |
| Field | Nanoplatforms for cancer theranostics |
| h-index | 94 |
| i10-index | 386 |
| Last Known Institution | Central South University |
| OpenAlex ID | https://openalex.org/A5063552401 |
| ORCID iD | https://orcid.org/0000-0003-1873-6510 |
| Works | 687 |

## Researcher papers

- [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/)

## Researcher topics

- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Luminescence and Fluorescent Materials](https://scholariq.org/topics/luminescence-and-fluorescent-materials/)
- [Advanced biosensing and bioanalysis techniques](https://scholariq.org/topics/advanced-biosensing-and-bioanalysis-techniques/)
- [Photodynamic Therapy Research Studies](https://scholariq.org/topics/photodynamic-therapy-research-studies/)
- [Assistive Technology in Communication and Mobility](https://scholariq.org/topics/assistive-technology-in-communication-and-mobility/)

## Researcher university

- [Central South University](https://scholariq.org/institutions/central-south-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.